Discontinued
OZEMPIC 0.25/0.5 mg semaglutide 1.34 mg/mL solution for injection pre-filled pen
Semaglutide · 1.34 mg/mL Injection, solution
- Deletion from market
- 31 Dec 2025
- TGA row last updated
- 24 Mar 2026
- ARTG ID
- 308324
- Sponsor
- Novo Nordisk Pharmaceuticals Pty Ltd
- Sponsor phone
- 1800668626
- Shortage impact
- Low
- Availability
- Reduction in supply until supply is exhausted
Reason reported to TGA
Commercial Changes / Commercial viability
TGA management action
This product has been replaced by ARTG 446290 - OZEMPIC 0.25 mg/0.5mg semaglutide (rys) 0.68 mg/mL solution for injection in 3mL pre-filled pen. Both presentations have been a-flagged, making them interchangeable on the PBS. The PBS Supply Only listing for the 1.5 mL Ozempic 0.25 mg/0.5 mg pre-filled pen has been extended to 1 June 2026. This means the 1.5 mL presentation remains available for dispensing but not for prescribing.
What to do
- 1.This product is discontinued in the TGA export — Ask your prescriber or pharmacist about a product that is still supplied. Do not stop treatment without that advice.
Official sources
Last updated from the TGA Medicine Shortage Reports Database (report generated 12 November 2026 10:15:07 PM).
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.